Artículos sobre Alzheimer
Artículos científicos publicados por los investigadores del Barcelonaβeta Brain Research Center (BBRC), relacionados con la enfermedad de Alzheimer, neuroimagen, memoria y enfermedades neurodegenerativas, entre otros campos.
-
Tort-Colet N, Stankeviciute L, Fernández-Arcos A, Soldevila-Domenech N, Sánchez-Benavides G, Shekari M, Vállez García D, Altomare D, Barkhof F, Boada M, Buckley C, Collij LE, den Braber A, Farrar G, Ford L, Frisoni GB, Gismondi R, Gispert JD, Grootoonk S, Hanseeuw BJ, Jessen F, Luckett ES, Manber R, Marquié M, Mett A, Quenon L, Ritchie C, Schmidt ME, Schöll M, Stephens AW, Vandenberghe R, Visser PJ, Wolz R, Grau-Rivera O; AMYPAD Consortium
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study
Alzheimer's Research & Therapy -
Kassinopoulos M, Montesinos P, Falcon C, Huguet J, Minguillon C, Fauria K, Kollmorgen G, Quijano-Rubio C, Molinuevo JL, Grau-Rivera O, Zetterberg H, Blennow K, Suárez-Calvet M, Sanchez-Gonzalez J, Gispert JD; ALFA study
Intracellular fluid accumulation underlies brain volume increases in early Alzheimer's disease
Brain CommunicationsAbstractIn the preclinical stages of Alzheimer's disease, increased brain volume has been associated with amyloid-beta pathology, particularly in regions that undergo volume reductions as the disease...
-
Collij LE, Bischof GN, Altomare D, Bader I, Battle M, Vállez García D, Lopes Alves I, Wolz R, Gismondi R, Stephens A, Walker Z, Scheltens P, Nordberg A, Gispert JD, Drzezga A, Perissinotti A, Morbelli S, Buckley C, Garibotto V, Frisoni GB, Farrar G, Barkhof F;
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
Journal of Nuclear MedicineAbstractSeveral studies have demonstrated strong agreement between routine clinical visual assessment and quantification, suggesting that quantification approaches could support assessment by less experienced...
-
Shekari M, Vállez García D, Collij LE, Altomare D, Heeman F, Pemberton H, Roé Vellvé N, Bullich S, Buckley C, Stephens A, Farrar G, Frisoni G, Klunk WE, Barkhof F, Gispert JD.
ADNI and the AMYPAD consortium. Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology. Alzheimers Dement
Alzheimers DementAbstractIntroduction: Assessing the potential sources of bias and variability of the Centiloid (CL) scale is fundamental for its appropriate clinical application.
Methods: We included 533 participants from...
-
Mastenbroek SE, Sala A, Vállez García D, Shekari M, Salvadó G, Lorenzini L, Pieperhoff L, Wink AM, Lopes Alves I, Wolz R, Ritchie C, Boada M, Visser PJ, Bucci M, Farrar G, Hansson O, Nordberg AK, Ossenkoppele R, Barkhof F, Gispert JD, Rodriguez-Vieitez E, Collij LE.
Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity
NeurologyAbstractBackground and objectives: Discordance between CSF and PET biomarkers of β-amyloid (Aβ) might reflect an imbalance between soluble and aggregated species, possibly reflecting disease heterogeneity...
-
Tranfa M, Lorenzini L, Collij LE, Vállez García D, Ingala S, Pontillo G, Pieperhoff L, Maranzano A, Wolz R, Haller S, Blennow K, Frisoni G, Sudre CH, Chételat G, Ewers M, Payoux P, Waldman A, Martinez-Lage P, Schwarz AJ, Ritchie CW, Wardlaw JM, Gispert JD, Brunetti A, Mutsaerts HJMM, Wink AM, Barkhof F.
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Annals of Clinical and Translational NeurologyAbstractObjective: Alzheimer's disease (AD) and cerebral small vessel disease (cSVD), the two most common causes of dementia, are characterized by white matter (WM) alterations diverging from the...
